Leidy Paola Prada Romero

Leidy Paola Prada Romero

Auto-generated profile, based on publicly available information

Leidy Paola Prada Romero

Sleep Medicine Center, Fundación Neumológica Colombiana, Bogota, Cundinamarca, Colombia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Revista Colombiana de Neumología
Verified
Journal Article
Open access
PDF file
OMOlga Milena García Morales
Olga Milena García Morales
AMAbraham Ali Munive
Abraham Ali Munive
CCCarlos Andrés Celis-Preciado
Carlos Andrés Celis-Preciado
DTDarío Londoño Trujillo
Darío Londoño Trujillo
ACAlejandro Casas
Alejandro Casas
WRWendy Rubiano
Wendy Rubiano
Introduction: Chronic obstructive pulmonary disease (COPD) represents a significant challenge both in the economic and public health realms, both globally and within the Colombian context. This condition not only affects the patients who suffer from it, but also impacts their caregivers and the healthcare system. An increase in absenteeism has been observed both among patients and their family members, resulting in economic losses and missed employment opportunities, further exacerbating the adverse impact on the individual and their family environment. The purpose of this clinical guideline is to establish evidence-based guidelines to improve medical care and resource management in the treatment of COPD within the Colombian population. Objective: This evidence-informed clinical practice guideline (CPG) from the Asociación Colombiana de Neumología y Cirugía de Tórax (Asoneumocito), Asociación Colombiana de Medicina Interna (ACMI) y Asociación colombiana de medicina familiar (SOCMEF) y Asociación Colombiana de Fisioterapia (ASCOFI), aims to support patients, health professionals, and other actors in making decisions about diagnosis. approach, prognosis, and management of adults with COPD in the Colombian context. Materials and methods: The COPD Committee of Asoneumocito, by delegation of the presidency of the latter, formed a multidisciplinary panel of experts to balance and minimize the potential bias arising from conflicts of interest and invited the other associations that were part of this guide. The Universidad de los Andes coordinated and developed the updating or de novo of systematic reviews of the literature according to the GRADE methodology (Grading of Recommendations Assessment, Development and Evaluation). The COPD committee asked a series of questions that the expert panel prioritized, as well as outcomes according to their importance to healthcare professionals and patients. We used the Evidence-to-Decision (EtD) frameworks developed by the GRADE working group, which were subject to public comment. Results: The panel developed 10 evidence-based recommendations for the management of patients with COPD who received any of the following interventions: long-term oxygen therapy, vaccination against influenza viruses, pulmonary rehabilitation, long-acting anticholinergic inhalation therapy, triple therapy inhalation therapy, nutritional supplements, adjunctive therapy with azithromycin, smoking cessation with varenicline, and alpha-1 antitrypsin replacement. Conclusions: The recommendations included in this guide were developed for the Colombian context. The panel considered that there is a need to develop studies of economic evaluations, as well as the impact of the interventions evaluated in areas such as equity, acceptability, and feasibility of implementation in Colombia.

7 March 2025 in Sleep Science
Verified
Journal Article
Open access
PDF file
GQGustavo Adolfo Gaitan Quintero
Gustavo Adolfo Gaitan Quintero
LRLeidy Paola Prada Romero
Leidy Paola Prada Romero
AGAna María González
Ana María González
MBMaría Angélica Bazurto-Zapata
María Angélica Bazurto-Zapata
Introduction At high altitudes, hypobaric hypoxia leads to central apneas in both healthy adults and patients with obstructive sleep apnea. This condition correlates with intermittent desaturation and disruption of sleep. Materials and Methods The clinical case of a patient evaluated during a sleep medicine outpatient consultation at the Fundación Neumológica Colombiana (Bogotá, Colombia, 2,600 masl) is reported. Case Study We present a 64-year-old male patient living in a high-altitude city, who was an aircrew member and was on continuous positive airway pressure (CPAP) therapy for severe obstructive sleep apnea (OSA). The patient had symptoms and central apneas only when he slept at high altitudes. Other causes of central apnea were ruled out, and these events were corrected with the administration of supplemental oxygen. Altitude-associated central apnea is a common disorder that can occur at altitudes higher than 1,600 m above sea level. Currently, the first-line treatments are acetazolamide and oxygen supplementation. Conclusions Changes in altitude should be considered in patients with OSA in PAP therapy, as it can occur in many occupations and in recreational travels.

1 September 2026 in Respirar
Verified
Journal Article
Open access
PDF file
LJLibardo Jiménez-Maldonado
Libardo Jiménez-Maldonado
MGM. Victoria Guerrero
M. Victoria Guerrero
CBCatalina Bazurto
Catalina Bazurto
LPLeidy Prada
Leidy Prada
APAngelica Pachon
Angelica Pachon
AAAbraham Alí-Munive
Abraham Alí-Munive
Introducción: El impacto de clínicas especializadas en asma grave en el control de la enfermedad, en países de ingresos medios como Colombia, es limitado. Objetivo: Determinar el impacto de ASMAIRE REXPIRA, en una cohorte de pacientes con asma grave en términos de desenlaces clínicos. Métodos: Estudio de mundo real, retrospectivo, observacional, diseño antes-después, en pacientes ≥ 18 años con asma grave (ICS/LABA a dosis alta, paso 5 GINA 2020) que ingresaron en 2022 y completaron 2 años de seguimiento. Se comparó el año previo al ingreso con el primero y segundo año: exacerbaciones que requirieron corticosteroides orales (OCS), atención en urgencias u hospitalización, síntomas (ACT y ACQ-5), VEF1 pre y post broncodilatador (BD) y calidad de vida (miniAQLQ). Resultados: Se incluyeron 196 pacientes, 80,1% mujeres, edad promedio 51,9 años, IMC 27,8. Al primer año, el porcentaje de pacientes con asma controlada aumentó de 49,7% a 64,1%, manteniéndose en 70,4% al segundo año (p<0,001). La tasa de exacerbaciones que requirieron OCS, urgencias u hospitalizaciones disminuyó 67%, 69% y 78%, respectivamente, el primer año y continuó disminuyendo el segundo año. La calidad de vida mejoró significativamente al primer y segundo año (p<0,001). No se observaron diferencias significativas en el VEF1. Conclusiones: El manejo interdisciplinario y sistemático del asma grave en una clínica especializada como ASMAIRE REXPIRA mejora significativamente el control de la enfermedad. Este modelo de atención podría representar una alternativa costo-efectiva que requiere evaluación económica formal y puede promoverse en otros centros de Latinoamérica para reducir la carga de la enfermedad.